Labile Copper Test Enhances Evaluation for Wilson's Disease: Joshua Bornhorst, Ph.D.

Update: 2025-07-01

Description

Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' labile copper assay (Mayo ID: LBCS) improves upon standard blood tests for Wilson's disease. The new test measures not just overall copper but also the fraction of copper that is bioavailable, or labile bound.

(00:32 )
Can you tell us a little bit about yourself and your background?

(01:33 )
Could you give us a brief overview of this assay?

(02:47 )
Which patients should have this testing, and when should it be performed?

(03:48 )
How would the results be used in patient care?

Comments

In Channel

Developments for LDT Regulation and Laboratory Reimbursement: Bill Morice, M.D., Ph.D.

2025-10-1615:52

Self-Collection Testing Expands to New Areas: Elitza Theel, Ph.D.

2025-10-0214:16

Flesh-Eating Organisms Making the News: Bill Morice, M.D., Ph.D.

2025-09-1115:44

Whole Exome Sequencing Reflex Test Offers Cost-Effective Diagnosis: Cherisse Marcou, Ph.D., and Kristen Rasmussen, M.S., CGC

2025-09-0222:13

Rabbits, Chikungunya, and More Viral News: Matthew Binnicker, Ph.D.

2025-08-2821:21

The Promise, Challenges, and Global Impact of AI Tools: Bill Morice, M.D., Ph.D.

2025-08-1411:20

New Tools for the Changing Landscape of Tick-Borne Diseases: Elitza Theel, Ph.D.

2025-07-3115:33

How Investment Trends May Impact Clinical Diagnostics: Bill Morice, M.D., Ph.D.

2025-07-1712:32

Expanded assay better identifies hereditary pancreatitis: Linda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGC

2025-07-1511:16

How the Evolving Role of Diagnostics and Platforms Impact Healthcare: Bill Morice, M.D., Ph.D.

2025-07-0314:23

Labile Copper Test Enhances Evaluation for Wilson's Disease: Joshua Bornhorst, Ph.D.

2025-07-0106:51

Assay Aids Diagnosis of Resistant Hypertension: John Lieske, M.D., and Sandra Taler, M.D.

2025-06-2411:49

Advancing Neuropathy Diagnosis With Laboratory Testing and Algorithms: Div Dubey, M.B.B.S

2025-06-1916:20

Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D.

2025-06-1712:21

Global Diagnostic Trends and What They Mean for Laboratories: Bill Morice, M.D., Ph.D.

2025-06-0514:32

Five Ways Laboratories Maximize Health System Success: Bill Morice, M.D., Ph.D.

2025-05-2222:05

Laboratory Medicine Central to Tick-Borne Disease Response: Bill Morice, M.D., Ph.D.

2025-05-0813:40

Revolutionary Technology Advances Diagnosis of Neurodegenerative Disorders: Bill Morice, M.D., Ph.D.

2025-04-2422:09

Reflex Test Guides Precise Care for Arsenic Exposure: Paul Jannetto, Ph.D.

2025-04-1510:34

What Happens Next? Lab-Developed Test Rule Vacated: Bill Morice, M.D., Ph.D.

2025-04-1012:05

00:00

Labile Copper Test Enhances Evaluation for Wilson's Disease: Joshua Bornhorst, Ph.D.

#box-pro-ellipsis-176111106092611{-webkit-line-clamp:2;}Labile Copper Test Enhances Evaluation for Wilson's Disease: Joshua Bornhorst, Ph.D.

Labile Copper Test Enhances Evaluation for Wilson's Disease: Joshua Bornhorst, Ph.D.

Mayo Clinic Laboratories

Labile Copper Test Enhances Evaluation for Wilson's Disease: Joshua Bornhorst, Ph.D.